ebm.bmj1d
Cross-sectional study of loss of life expectancy at different ages related to firearm deaths among black and white Americans
The burden of death due to firearms is an ongoing public health problem in the USA. US men had a 21% life expectancy loss due to firearms compared with men from other countries.1 In 2016, 7.8% of the ...
ebm.bmj6d
Online First
Quantifying the time-varying association between objectively measured physical activity and mortality in US older adults over a 12-year follow-up period: the NHANES 2003–2006 study ...
ebm.bmj15d
Rapid reviews methods series: considerations and recommendations for evidence synthesis in rapid reviews
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj29d
Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane
Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...
ebm.bmj1mon
Evidence-based practice education for healthcare professions: an expert view
Correspondence to Dr Elaine Lehane, Catherine McAuley School of Nursing and Midwifery, University College Cork, Cork T12 K8AF, Ireland; e.lehane{at}ucc.ie To highlight and advance clinical ...
ebm.bmj1mon
Do infographics ‘spin’ the findings of health and medical research?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...
ebm.bmj2mon
How good is the evidence to support primary care practice?
Correspondence to Dr Mark H Ebell, Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, 125 Miller Hall, UGA Health Sciences Campus, Athens, GA 30602, USA; ...
ebm.bmj2mon
Informing treatment decisions through meta-analysis: to network or not?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
ebm.bmj2mon
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps
Accelerating Food and Drug Administration (FDA) product approval to market based on surrogate markers in the absence of proven efficacy creates a risk of adverse outcomes for affected patients, even ...